Table 2.
Clinicopathological features of bladder cancers in HCV-infected patients and non-infected patients
| Criteria | HCV infected patients | Non-HCV patients | P value |
|---|---|---|---|
|
Age |
57.6±8.59 |
57.9±9.45 |
NS |
| Minimum = 36 |
Minimum = 42 |
||
| Maximum = 79 |
Maximum = 80 |
||
|
Sex |
|
|
|
| - Male |
43 (86%) |
42 (84%) |
NS |
| - Female |
7 (14%) |
8 (16%) |
|
|
Histopathological type |
|
|
|
| - TCC |
32 (64%) |
19 (38%) |
p= 0.009 |
| - SCC |
18 (36%) |
31 (62%) |
|
|
Tumour grade |
|
|
|
| - Grade I |
10 (20%) |
26 (52%) |
p= 0.000 |
| - Grade II |
19 (38%) |
19 (38%) |
|
| - Grade III |
21 (42%) |
5 (10%) |
|
|
Lymph Nodes (LNs) |
|
|
|
| - Negative LNs |
38 (76%) |
40 (80%) |
NS |
| - Positive LNs |
12 (24 %) |
10 (20%) |
|
|
Tumour staging |
|
|
|
|
- Stage (Ta) |
1 (2%) |
5 (10%) |
p= 0.002 |
|
- Stage (T1) |
12 (24%) |
17 (34%) |
|
|
- Stage (T2) |
13 (26%) |
15 (30%) |
|
|
- Stage (T3) |
12 (24%) |
8 (16%) |
|
|
- Stage (T4) |
12 (24%) |
5 (10%) |
|
|
Metastases |
|
|
|
| - Negative |
43 (86%) |
42 (84%) |
NS |
| - Positive | 7 (14%) | 8 (16%) |
P= chi square test with significance of p ≤ 0.05.